PRESS RELEASE published on 10/30/2025 at 09:00, 10 months 30 days ago Press Release Publication Half-Year Financial Report 2025 Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
PRESS RELEASE published on 10/30/2025 at 08:58, 10 months 30 days ago Communiqué de presse Mise à disposition du rapport semestriel 2025 Valerio Therapeutics annonce ses résultats financiers du 1er semestre 2025 et fait le point sur ses activités. Renforcement de la R&D préclinique avec les plateformes V-Body et chimie intégrée Résultats Financiers Valerio Therapeutics R&D Préclinique V-Body Chimie Intégrée
BRIEF published on 03/19/2025 at 15:32, 1 year 6 months ago Valerio Therapeutics annonce la composition de son conseil d'administration et leurs fonctions Membres Du Conseil D'administration Valerio Therapeutics Rôles En Entreprise Entreprise Basée À Paris Responsabilités Exécutives
BRIEF published on 03/19/2025 at 15:32, 1 year 6 months ago Valerio Therapeutics Announces Board Members and Their Roles Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE published on 03/19/2025 at 15:27, 1 year 6 months ago Inside Information / Other news releases Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025 Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF published on 03/19/2025 at 12:35, 1 year 6 months ago Décisions du conseil d'administration de Valerio Therapeutics Assemblée Des Actionnaires Fractionnement Des Actions Changements De Directeur Résolutions Du Conseil D'administration Modifications D'articles
BRIEF published on 03/19/2025 at 12:35, 1 year 6 months ago Valerio Therapeutics Board Meeting Decisions Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Rapport du conseil d'administration de VALERIO THERAPEUTICS pour l'AG mixte des actionnaires du 9 avril 2025 concernant révocations, cooptations, division du nominal des actions et modifications statutaires Cooptation Revocation Valerio Therapeutics AG Mixte Division Du Nominal
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year 6 months ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF published on 02/04/2025 at 10:40, 1 year 7 months ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
Published on 09/29/2026 at 23:00, 52 minutes ago Abasca Resources Closes Non-Brokered Private Placement of $2.25 Million
Published on 09/29/2026 at 22:15, 1 hour 37 minutes ago CANEX Closes Oversubscribed $9.5 Million Equity Financing
Published on 09/29/2026 at 22:00, 1 hour 52 minutes ago Rocky Shore Closes Springdale Property Acquisition and Completes Initial Payments Under the Handcamp Property Option Agreement
Published on 09/29/2026 at 16:45, 7 hours 7 minutes ago Gold Terra Announces Visible Mineralization in Hole CMUP-005 in Early Sonic Drilling at the Con Mine Historical Tailings, Yellowknife, NWT
Published on 09/29/2026 at 21:30, 2 hours 22 minutes ago Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Published on 09/29/2026 at 19:47, 4 hours 5 minutes ago EQS-Adhoc: Marley Spoon Group SE: MARLEY SPOON GROUP SE REPORTS H1 2026 RESULTS AND GUIDANCE FOR 2026
Published on 09/29/2026 at 19:15, 4 hours 37 minutes ago Pensão Amor: Discover Lisbon's Most Surprising Hotel
Published on 09/29/2026 at 19:14, 4 hours 38 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 19:14, 4 hours 38 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 17:40, 6 hours 12 minutes ago Infotel : Mise à disposition du rapport financier semestriel 2026.
Published on 09/29/2026 at 17:40, 6 hours 12 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 31.08.26.
Published on 09/29/2026 at 14:15, 9 hours 37 minutes ago 260929 BENETEAU Mise en oeuvre du programme de rachat d'actions
